These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24468195)

  • 1. Complement components as potential therapeutic targets for asthma treatment.
    Khan MA; Nicolls MR; Surguladze B; Saadoun I
    Respir Med; 2014 Apr; 108(4):543-9. PubMed ID: 24468195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement mediators: key regulators of airway tissue remodeling in asthma.
    Khan MA; Assiri AM; Broering DC
    J Transl Med; 2015 Aug; 13():272. PubMed ID: 26289385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Value of Targeting Complement Components in Asthma.
    Mohamed MME; Nicklin AD; Stover CM
    Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32806638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma.
    Hawlisch H; Wills-Karp M; Karp CL; Köhl J
    Mol Immunol; 2004 Jun; 41(2-3):123-31. PubMed ID: 15159057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A complex role for complement in allergic asthma.
    Zhang X; Köhl J
    Expert Rev Clin Immunol; 2010 Mar; 6(2):269-77. PubMed ID: 20402389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and function of anaphylatoxins and their receptors in allergic asthma.
    Laumonnier Y; Wiese AV; Figge J; Karsten C
    Mol Immunol; 2017 Apr; 84():51-56. PubMed ID: 27916272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for the C3a anaphylatoxin receptor in the effector phase of asthma.
    Humbles AA; Lu B; Nilsson CA; Lilly C; Israel E; Fujiwara Y; Gerard NP; Gerard C
    Nature; 2000 Aug; 406(6799):998-1001. PubMed ID: 10984054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.
    Maruo K; Akaike T; Ono T; Okamoto T; Maeda H
    J Allergy Clin Immunol; 1997 Aug; 100(2):253-60. PubMed ID: 9275149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma.
    Krug N; Tschernig T; Erpenbeck VJ; Hohlfeld JM; Köhl J
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1841-3. PubMed ID: 11734433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement in asthma: sensitivity to activation and generation of C3a and C5a via the different complement pathways.
    Wust SK; Blumenthal MN; Corazalla EO; Benson BA; Dalmasso AP
    Transl Res; 2006 Oct; 148(4):157-63. PubMed ID: 17002917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
    Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
    J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement factor C5 inhibition reduces type 2 responses without affecting group 2 innate lymphoid cells in a house dust mite induced murine asthma model.
    Yang J; Ramirez Moral I; van 't Veer C; de Vos AF; de Beer R; Roelofs JJTH; Morgan BP; van der Poll T
    Respir Res; 2019 Jul; 20(1):165. PubMed ID: 31340811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylatoxins: their role in bacterial infection and inflammation.
    Haas PJ; van Strijp J
    Immunol Res; 2007; 37(3):161-75. PubMed ID: 17873401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylatoxin C3a receptors in asthma.
    Ali H; Panettieri RA
    Respir Res; 2005 Feb; 6(1):19. PubMed ID: 15723703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma.
    Lajoie S; Lewkowich IP; Suzuki Y; Clark JR; Sproles AA; Dienger K; Budelsky AL; Wills-Karp M
    Nat Immunol; 2010 Oct; 11(10):928-35. PubMed ID: 20802484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.
    Ali H
    Immunol Lett; 2010 Jan; 128(1):36-45. PubMed ID: 19895849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.
    Baelder R; Fuchs B; Bautsch W; Zwirner J; Köhl J; Hoymann HG; Glaab T; Erpenbeck V; Krug N; Braun A
    J Immunol; 2005 Jan; 174(2):783-9. PubMed ID: 15634899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylatoxins coordinate innate and adaptive immune responses in allergic asthma.
    Schmudde I; Laumonnier Y; Köhl J
    Semin Immunol; 2013 Feb; 25(1):2-11. PubMed ID: 23694705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of complement in the diagnosis and management of allergic rhinitis and allergic asthma.
    Laumonnier Y; Schmudde I; Köhl J
    Curr Allergy Asthma Rep; 2011 Apr; 11(2):122-30. PubMed ID: 21170614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
    J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.